MedPath

HOSPIRA, INC.

HOSPIRA, INC. logo
🇺🇸United States
Ownership
Subsidiary
Established
2004-01-01
Employees
19K
Market Cap
-
Website
http://hospira.com

Clinical Trials

3

Active:2
Completed:1

Trial Phases

1 Phases

Phase 1:2

Drug Approvals

204

FDA:204

Drug Approvals

Testosterone Cypionate

Approval Date
Jun 18, 2025
FDA

Testosterone Cypionate

Approval Date
Jun 17, 2025
FDA

Hydromorphone Hydrochloride

Approval Date
May 6, 2025
FDA

Cytarabine

Approval Date
Apr 7, 2025
FDA

Sterile Water

Approval Date
Dec 16, 2024
FDA

DEMEROL

Approval Date
Apr 5, 2024
FDA

Bumetanide

Approval Date
Apr 3, 2024
FDA

Bivalirudin

Approval Date
Apr 2, 2024
FDA

Butorphanol Tartrate

Approval Date
Apr 1, 2024
FDA

PROPOFOL

Approval Date
Mar 29, 2024
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 21
  • Next

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (100.0%)
No trials found

News

Gland Pharma Receives US FDA Approval for Phytonadione Injectable Emulsion

Gland Pharma has secured US FDA approval for its phytonadione injectable emulsion, a generic version of vitamin K1 injectable emulsion.

© Copyright 2025. All Rights Reserved by MedPath